Rutgers researchers have discovered a new system to deliver antimicrobial agents -- drugs, antiseptics or pesticides -- that could more effectively treat or prevent bacterial infections.
In a recent study in the Journal of The American Chemical Society, professor Tewodros Asefa and associate professor Jeffrey Boyd synthesized nanostructured silica particles, considered to be promising drug carriers, that contained payloads of an antimicrobial agent. The researchers found that the particles were effective at killing two human bacterial pathogens.
“Interestingly, the particles were more effective at killing the bacteria than the antimicrobial was, which may highlight a more efficient mechanism for drug delivery,” said Boyd, an Associate Professor in the Department of Biochemistry and Microbiology.
According to Boyd, bacteria are rapidly evolving and becoming resistant to antimicrobials â agents that kill or prevent the growth of microorganisms such as bacteria, viruses or fungi. The findings of this study could help them develop an antimicrobial therapy that would prevent bacterial infections or the growth of bacteria in unwanted locations.
This new mechanism allows compounds to slowly release antimicrobials into local environments, resulting in high amounts of the molecule in a specific location. This is a different scenario than when antibiotics are taken orally and they become widely distributed throughout the body.
“The new materials we have designed and built allow antibacterials to be more potent and have the ability to wipe out bacteria at smaller concentrations than the antibacterials can do on their own,” said Asefa, a Professor in the Department of Chemistry and Chemical Biology and the Department of Chemical and Biochemical Engineering. “This is because the newly designed nanomaterials allow the antibacterials to be localized, released slowly and attack the microorganism more effectively.”
Rutgers researchers say the study could lead to the development of new microscopic particles containing drugs, anticeptics or pesticides that may increase the effectiveness of the therapy and aid in preventing antibacterial resistance. What they still need to determine is why these microscopic particles containing the antibacterial agents are more effective at destroying the bacteria than the antibacterial alone.
Source: Rutgers University-New Brunswick
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.